Development Level

Tchem 5 | 1,890
Tclin 1 | 602

IMPC Phenotype

abnormal behavior 1 | 226
abnormal femur morphology 1 | 14
preweaning lethality, complete... 1 | 633

Disease

Cancer 6 | 2,346
Arthritis 4 | 248
Mammary Neoplasms 4 | 410
ovarian cancer 4 | 8,491
psoriasis 4 | 6,685
Asthma 3 | 349
Cardiomegaly 3 | 66
Inflammatory bowel disease 3 | 142
Kidney disease 3 | 397
Vascular disease 3 | 281
diabetes mellitus 3 | 1,663
glioblastoma 3 | 5,572
lung cancer 3 | 4,473
osteosarcoma 3 | 7,933
Alzheimer's disease 2 | 644
Atherosclerosis 2 | 275
Blastic phase chronic myeloid leukemia 2 | 58
Brain Ischemia 2 | 87
Carcinoma 2 | 2,147
Carcinoma of colon 2 | 32
Cardiomyopathies 2 | 90
Chronic Myelocytic Leukemia Accelerated Phase 2 | 59
Chronic phase chronic myeloid leukemia 2 | 45
Colonic Neoplasms 2 | 126
Fibrosis 2 | 40
Heart disease 2 | 279
Inflammation 2 | 109
Liver disease 2 | 219
Lung disease 2 | 136
Obesity 2 | 616
Osteoporosis 2 | 259
Pancreatic Neoplasm 2 | 79
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 2 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 2 | 47
Prostate cancer 2 | 172
Prostatic Neoplasms 2 | 471
Rheumatoid Arthritis 2 | 1,170
Squamous cell carcinoma 2 | 96
Stomach Neoplasms 2 | 282
Toxic encephalopathy 2 | 131
astrocytoma 2 | 1,493
atypical teratoid / rhabdoid tumor 2 | 4,369
colon cancer 2 | 1,475
cystic fibrosis 2 | 1,670
ependymoma 2 | 2,514
group 3 medulloblastoma 2 | 2,254
lung adenocarcinoma 2 | 2,714
non-small cell lung cancer 2 | 2,798
ovarian neoplasm 2 | 97
Adenocarcinoma 1 | 115
Adenomatous Polyposis Coli 1 | 10
Adult T-Cell Lymphoma/Leukemia 1 | 30
Agammaglobulinemia 1 | 24
Animal Mammary Neoplasms 1 | 135
Arthritis, Experimental 1 | 39
Atrophic 1 | 10
Brain disease 1 | 84
Breast adenocarcinoma 1 | 8
COPD 1 | 116
Candidiasis 1 | 48
Central sleep apnea 1 | 12
Colitis 1 | 46
Colon Carcinoma 1 | 25
Colorectal Cancer 1 | 62
Colorectal Neoplasms 1 | 217
Cowden disease 1 | 20
Diabetes Mellitus, Insulin-Dependent 1 | 77
Diabetic Retinopathy 1 | 53
Familial adenomatous polyposis 1 | 33
Fatty liver disease 1 | 86
Gastrointestinal system disease 1 | 50
Hodgkin Disease 1 | 16
Hyperglycemia 1 | 120
Hypohidrotic ectodermal dysplasia with immunodeficiency 1 | 2
Immune system cancer 1 | 38
Infarction, Middle Cerebral Artery 1 | 25
Job's syndrome 1 | 4
Leukemia, Myelocytic, Acute 1 | 113
Liver neoplasms 1 | 108
Lung Neoplasms 1 | 171
Lymphatic Metastasis 1 | 14
Lymphoid leukemia 1 | 69
Mammary Neoplasms, Experimental 1 | 149
Meningioma 1 | 27
Muscular atrophy 1 | 67
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neurofibromatosis 1 | 37
Opitz-GBBB syndrome 1 | 19
Osteopetrosis 1 | 40
Pain 1 | 70
Pancreatitis 1 | 97
Pneumonia 1 | 133
Psychoses, Substance-Induced 1 | 17
Retinal Degeneration 1 | 49
Skin Neoplasms 1 | 49
Skin cancer 1 | 37
Skin disease 1 | 65
T-Cell Lymphoma 1 | 11
Uterine Cervical Neoplasm 1 | 21

Tissue

Blood and immune system 6 | 17,994
Cardiovascular System 6 | 17,957
Digestive Tract 6 | 18,472
Endocrine System 6 | 18,511
Female tissues 6 | 18,646
Liver and Pancreas 6 | 18,135
Male tissues 6 | 17,968
Nervous System 6 | 18,560
Respiratory system 6 | 17,483
Skin and soft tissues 6 | 18,114
Urinary Tract 6 | 18,443

Target Family

Kinase 3 | 634
Enzyme 1 | 4,146
Non-IDG 1 | 11,969
Transcription Factor 1 | 1,400

Grant Application

5R37DK016505-38 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Signal transducer and activator of transcription 3 STAT3 Tchem Transcription Factor -3.75815 5706.6 1539
Ephrin type-B receptor 2 EPHB2 Tchem Kinase -2.66552 472.2 420
Proto-oncogene tyrosine-protein kinase Src SRC Tclin Kinase -3.98540 8801.0 1257
NF-kappa-B inhibitor alpha NFKBIA Tchem Non-IDG -3.34592 1960.9 1181
Serine/threonine-protein phosphatase 2A activator PTPA Tchem Enzyme -3.23751 1739.9 187
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.32386 18275.3 3137